Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

249 Views

248. Treatment of Antimicrobial-Resistant Infections: Saturday, 12:15 - 1:30 p.m.

Poster Session: Treatment of Antimicrobial-Resistant Infections

(2790) Activity of Cefiderocol and Comparator Agents Against Pediatric Isolates of Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii-calcoaceticus species complex, and Stenotrophomonas maltophilia from the SENTRY Surveillance Program (2020-2022)

Saturday, October 14, 2023

12:15 PM - 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Sean T. Nguyen, PharmD

Director, Medical Affairs
Shionogi Inc.
Florham Park, New Jersey, United States

Boudewijn L. DeJonge, PhD (he/him/his)

Director Microbiology
Shionogi Inc.
Florham Park, New Jersey, United States
JB

Jason J. Bryowsky, PharmD, MS

Director, Field Microbiology
Shionogi Inc.
Florham Park, New Jersey, United States
AH

Anne Henriksen, PhD

Shionogi BV
Copenhagen, Hovedstaden, Denmark
CL

Christopher M. Longshaw, PhD

Senior Director, Scientific Affairs EU
Shionogi B.V.
London, England, United Kingdom
JM

Joshua Maher, PhD

Research Scientist
JMI Laboratories
North Liberty, Iowa, United States
Rodrigo E. Mendes, PhD (he/him/his)

Director of Microbiology & Molecular Biology
JMI Laboratories
North Liberty, Iowa, United States
MT

Miki Takemura, n/a

Director, Head of Infectious Diseases 5, Laboratory for Drug Discovery and Disease Research
Shionogi & Co., Ltd
Toyonaka, Osaka, Japan
Yoshinori Yamano, PhD (he/him/his)

Chief Scientific Officer for Infectious Diseases
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan